/* 배경화면 투명도 제거 설정 */

[AHA 2012] The Impact of Anemia Severity on Angiographic and Clinical Outcomes following Percutaneous Coronary Intervention with Drug-eluting Stents in Asian Population

Abstracts and presentations are embargoed for release at date and time of presentation or time of AHA/ASA news event. Information may not be released before then. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation.

Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and Lifestyle

Session Title: Outcomes and Prognostic Markers in CVD

Abstract 18780: The Impact of Anemia Severity on Angiographic and Clinical Outcomes following Percutaneous Coronary Intervention with Drug-eluting Stents in Asian Population

Ji Young Park1; Seung Woon Rha2; Jae Woong Choi1; Sung Kee Ryu1; Byoung Geol Choi2; Se Yeon Choi2; Sung Il Im2; Sun Won Kim2; Jin Oh Na2; Seong Woo Han2; Cheol Ung Choi2; Hong Euy Lim2; Jin Won Kim2; Eung Ju Kim2; Chang Gyu Park2; Hong Seog Seo2; Dong Joo Oh2

1 Cardiology department, Eulji Univ, Eulji General Hosp, Seoul, Korea, Republic of
2 Cardiovascular Cntr, Korea Univ Guro Hosp, Seoul, Korea, Republic of

Background: The significance of anemia in patients (pts) undergoing percutaneous coronary intervention (PCI) remains controversial. The aim of this study was to evaluate the impact of the severity of anemia on the angiographic and clinical outcomes following PCI with drug eluting stent (DES).

Methods: A total of 881 consecutive pts underwent PCI with DESs were enrolled. Anemia was defined using World Health Organization criteria with hematocrit (Hct): mild anemia (female: 29%≤Hct<36%, male:29%≤Hct<39%, A1, n=485), moderate to severe anemia (Hct<29%, A2, n=50), and no anemia (female: Hct≥36%, male: Hct≥39%, A0, n=507). Six-month angiographic and 1 year clinical outcomes were compared among the three groups.

Results: At baseline, the rate of female gender, old age, the incidence of ST elevation myocardial infarction (STEMI), hypertension, diabetes mellitus, chronic renal disease, and congestive heart failure were highest in the Group A2. The incidence of left main and multivessel PCI was highest in the Group A2. At 6 months, the angiographic outcomes were worst in the Group A2. At 12 months, the cumulative incidence of total deaths, any myocardial infarction, and all major adverse cardiac events (MACEs) up to 2 years were highest in the Group A2 (Table). Multivariate analysis showed that anemia was an independent predictor of mortality at 2 years (Adjusted OR 3.78, CI 2.19-6.52, p<0.001).

Conclusions: In conclusion, the severity of anemia on admission in pts undergoing PCI with DESs was associated with higher mortality and MACEs up to 2 years, suggesting special care should be exercised when a pt has moderate to severe anemia on admission.

Formula

Author Disclosures: J. Park: None. S. Rha: None. J. Choi: None. S. Ryu: None.B. Choi: None. S. Choi: None. S. Im: None. S. Kim: None. J. Na: None. S. Han:None. C. Choi: None. H. Lim: None. J. Kim: None. E. Kim: None. C. Park:None. H. Seo: None. D. Oh: None.


Key Words: Risk factors • Percutaneous coronary intervention

추천 0 공유 · 더보기 목록

댓글 0